Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

arginyl-phenylalanyl-valyl-prolyl-aspartyl-glycyl-asparagyl-arginyl-isoleucine MeSH Supplementary Concept Data 2025


MeSH Supplementary
arginyl-phenylalanyl-valyl-prolyl-aspartyl-glycyl-asparagyl-arginyl-isoleucine
Unique ID
C578462
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C578462
Entry Term(s)
Arg-Phe-Val-Pro-Asp-Gly-Asn-Arg-Ile
RFVPDGNRI
VEGFR2-169 peptide
elpamotide
Registry Numbers
0
Heading Mapped to
*Peptide Fragments
*Vascular Endothelial Growth Factor Receptor-2
Frequency
4
Note
elpamotide is a vaccine consisting of VEGFR2-169 peptide
Source
Cancer Sci. 2010 Feb;101(2):433-9.
Indexing Information
Cancer Vaccines
Vaccines, Subunit
Date of Entry
2013/02/24
Revision Date
2013/02/24
arginyl-phenylalanyl-valyl-prolyl-aspartyl-glycyl-asparagyl-arginyl-isoleucine Preferred
elpamotide Narrower
page delivered in 0.007s